{"id":"W4405589202","doi":"10.1182/blood.2024026299","title":"Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Samsung; Novo Nordisk; Argenx; Incyte; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; BioCryst; Janssen Pharmaceuticals; Gilead Sciences; Sanofi; Celgene; Universität Ulm; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Chugai Pharmaceutical; Agios Pharmaceuticals","keywords":"Eculizumab; Medicine; Term (time); Intensive care medicine; Pediatrics; Immunology; Antibody; Complement system; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001218774,0.0003978646,0.001202558,0.0002105034,0.0002648174,0.0004552187,0.0004714134,0.0006301414,0.001651422],"category_scores_gemma":[0.001166092,0.0001899047,0.0005511046,0.0001478063,0.0002965395,0.0004389336,0.0002143455,0.001273145,0.0003259044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006099415,"about_ca_system_score_gemma":0.0004814719,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006476602,"about_ca_topic_score_gemma":0.001332153,"domain_scores_codex":[0.9995818,0.0001588905,0.00003389045,0.000071248,0.00007177544,0.00008248479],"domain_scores_gemma":[0.9993696,0.0001034802,0.0001422181,0.0000480354,0.00006750518,0.0002691738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7396155,0.02373033,0.01531142,0.0009330326,0.001611278,0.0002694714,0.0001413543,0.0008756904,0.02950882,0.0001088085,0.002239328,0.1856549],"study_design_scores_gemma":[0.1761987,0.6362415,0.1703116,0.0001969647,0.001616991,0.0006929149,0.0001308976,0.001779722,0.009321157,0.0001505799,0.003285138,0.00007380106],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962286,0.002616947,0.00008972749,0.00008606425,0.00004644199,0.0001455189,0.0001758935,0.00001859552,0.000592209],"genre_scores_gemma":[0.9983208,0.0005605497,0.0001641923,0.0001511932,0.00004330913,0.0001287954,0.0002372616,0.000003003515,0.0003909768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001651422,"threshold_uncertainty_score":0.006445587,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01853142794094673,"score_gpt":0.2812584213902983,"score_spread":0.2627269934493516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}